Mariotto, Sara
 Distribuzione geografica
Continente #
NA - Nord America 6.621
EU - Europa 6.087
AS - Asia 5.109
SA - Sud America 823
AF - Africa 194
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 18.867
Nazione #
US - Stati Uniti d'America 6.466
RU - Federazione Russa 2.941
SG - Singapore 2.095
CN - Cina 1.361
IT - Italia 739
BR - Brasile 663
GB - Regno Unito 619
VN - Vietnam 517
HK - Hong Kong 434
DE - Germania 332
FR - Francia 325
SE - Svezia 306
IE - Irlanda 305
KR - Corea 173
FI - Finlandia 167
IN - India 93
CA - Canada 89
AR - Argentina 68
JP - Giappone 62
ID - Indonesia 61
BD - Bangladesh 52
NL - Olanda 49
PL - Polonia 48
UA - Ucraina 47
ZA - Sudafrica 45
ES - Italia 44
MX - Messico 38
TR - Turchia 37
IQ - Iraq 36
BE - Belgio 35
AT - Austria 32
TG - Togo 29
AU - Australia 27
NG - Nigeria 27
BJ - Benin 25
PK - Pakistan 25
IR - Iran 23
EC - Ecuador 21
CL - Cile 19
MA - Marocco 19
LT - Lituania 18
SA - Arabia Saudita 17
UZ - Uzbekistan 17
VE - Venezuela 16
AE - Emirati Arabi Uniti 15
CO - Colombia 13
EG - Egitto 11
PH - Filippine 11
KE - Kenya 10
CH - Svizzera 9
JM - Giamaica 9
JO - Giordania 9
IL - Israele 8
PY - Paraguay 8
RO - Romania 8
TN - Tunisia 8
PT - Portogallo 7
CZ - Repubblica Ceca 6
KZ - Kazakistan 6
NP - Nepal 6
UY - Uruguay 6
BG - Bulgaria 5
HR - Croazia 5
LB - Libano 5
OM - Oman 5
PE - Perù 5
SY - Repubblica araba siriana 5
AL - Albania 4
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
GR - Grecia 4
LU - Lussemburgo 4
ML - Mali 4
PA - Panama 4
PS - Palestinian Territory 4
TW - Taiwan 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
DK - Danimarca 3
DZ - Algeria 3
HU - Ungheria 3
KG - Kirghizistan 3
KW - Kuwait 3
LK - Sri Lanka 3
LV - Lettonia 3
MY - Malesia 3
RS - Serbia 3
TH - Thailandia 3
AM - Armenia 2
BH - Bahrain 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
GE - Georgia 2
MD - Moldavia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
SN - Senegal 2
SV - El Salvador 2
Totale 18.839
Città #
Singapore 1.080
Ashburn 1.068
Moscow 1.022
San Jose 725
Dallas 706
Chandler 689
Hong Kong 430
Southend 414
Verona 325
Beijing 293
Dublin 291
The Dalles 229
New York 176
Ho Chi Minh City 171
Los Angeles 161
Woodbridge 157
Jacksonville 131
Ann Arbor 111
Hanoi 108
Lawrence 98
Princeton 98
Wilmington 85
Helsinki 79
Munich 73
Jinan 71
Houston 68
Dearborn 66
Redondo Beach 62
São Paulo 61
London 55
Shenyang 55
Santa Clara 54
Buffalo 53
Nanjing 53
Redmond 53
Sindelfingen 52
Tokyo 48
Milan 46
Orem 46
Warsaw 45
Columbus 43
Council Bluffs 43
Hebei 43
Tianjin 42
Jakarta 41
Washington 39
Montreal 37
Dong Ket 36
Seattle 35
Brussels 34
Phoenix 34
Guangzhou 33
Seoul 33
Brooklyn 31
Chicago 31
Lappeenranta 31
Boardman 30
Frankfurt am Main 29
Lomé 29
Nuremberg 29
Denver 28
Changsha 27
Ningbo 27
Turku 26
Abuja 25
Bologna 25
Cotonou 25
Johannesburg 24
Zhengzhou 24
Amsterdam 23
Hangzhou 23
Adelaide 22
Belo Horizonte 22
Chennai 22
Nanchang 22
Atlanta 21
Falls Church 21
Rio de Janeiro 21
Taiyuan 21
Haiphong 20
Poplar 20
Toronto 20
Da Nang 19
Paris 19
Haikou 18
Kent 18
Rome 17
Mexico City 16
Redwood City 16
Stockholm 16
Taizhou 16
Vienna 16
Baghdad 15
Boston 15
Norwalk 15
Bloomsbury 13
Falkenstein 13
Hải Dương 13
Mumbai 13
Tashkent 13
Totale 11.101
Nome #
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study 251
What is the role of the placebo effect for pain relief in neurorehabilitation? Clinical implications from the Italian Consensus Conference on Pain in Neurorehabilitation 243
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management 232
Cyclooxygenase 2, toll-like receptor 4 and interleukin 1beta mRNA expression in atherosclerotic plaques of type 2 diabetic patients. 232
Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders 232
Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder 224
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 214
Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases 209
A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes 209
Brentuximab vedotin: axonal microtubule's Apollyon 205
Time for a Consensus Conference on pain in neurorehabilitation 205
Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder 203
Anti-N-methyl-d-aspartate receptor encephalitis causing a prolonged depressive disorder evolving to inflammatory brain disease. 202
Humoral immunity response to HERV-K/W differentiates between amyotrophic lateral sclerosis and other neurological diseases 199
Assessing and treating pain in movement disorders, amyotrophic lateral sclerosis, severe acquired brain injury, disorders of consciousness, dementia, oncology and neuroinfectivology. Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation 197
Clinical and neurophysiological serial assessments of brentuximab vedotin-associated peripheral neuropathy 193
Neurosyphilis manifesting with rapidly progressive dementia: report of three cases. 191
Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD 183
Microglial and Neuronal TDP-43 Pathology in Anti-IgLON5-Related Tauopathy 183
Cauda equina syndrome caused by lumbosacral epidural lipomatosis. A case report. 183
Nervous system: subclinical target of SARS-CoV-2 infection 175
Chronic fatigue syndrome: an emerging sequela in COVID-19 survivors? 175
Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve 175
Acute cervical longitudinally extensive transverse myelitis in a child with Lipopolysaccharide-Responsive-Beige-Like-Anchor-Protein (LRBA) deficiency: a new complication of a rare disease 174
Neurological symptoms and axonal damage in COVID-19 survivors: are there sequelae? 174
A window into the mind-brain-body interplay: Development of diagnostic, prognostic biomarkers, and rehabilitation strategies in functional motor disorders 172
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype 169
Sural nerve biopsy: current role and comparison with serum neurofilament light chain levels 169
Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: Incidence, characteristics and long-term follow-up in a multicenter series 168
Antibodies to MOG in CSF only: pathological findings support the diagnostic value 167
Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis 165
MOG antibody seropositivity in a patient with encephalitis: beyond the classical syndrome 160
The original histological slides of Camillo Golgi and his discoveries on neuronal structure 160
Mycobacterium avium subspecies paratuberculosis and myelin basic protein specific epitopes are highly recognized by sera from patients with Neuromyelitis optica spectrum disorder 157
Serum and cerebrospinal neurofilament light chain levels in patients with acquired peripheral neuropathies 157
Association of Maintenance Intravenous Immunoglobulin With Prevention of Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease 154
Anti-MOG-associated demyelinating disorders: two sides of the same coin 152
Hypothalamic-Bulbar MRI hyperintensity in Anti-IgLON5 disease with serum-restricted antibodies: a case report and systematic review of literature 152
Application of the international criteria for optic neuritis in the Acute Optic Neuritis Network 148
Atypical myelin oligodendrocyte glycoprotein antibody-associated optic neuritis and acute demyelinating polyneuropathy after SARS-CoV-2 infection: Case report and literature review 148
GABA(A) receptor autoimmunity after alemtuzumab treatment for multiple sclerosis 148
Gender disparity in editorial boards of journals in neurology 148
Oligoclonal bands: clinical utility and interpretation cues 146
Autoimmune movement disorders complicating treatment with immune checkpoint inhibitors 145
Cognitive Profile in Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Comparative Study With Multiple Sclerosis 144
Late presentation of NMOSD as rapidly progressive leukoencephalopathy with atypical clinical and radiological findings 143
Diagnostic features of initial demyelinating events associated with serum MOG-IgG 143
Autoimmune encephalitis misdiagnosis and mimics 142
Is there a correlation between MOGAD and SARS-CoV-2 infection? 141
Inter-center agreement in the interpretation of oligoclonal bands 140
A score that predicts aquaporin-4-IgG positivity in patients with longitudinally extensive transverse myelitis 139
Epileptic seizures of suspected autoimmune origin: a multicentre retrospective study 139
HCV-related nervous system disorders. 138
Clinical Neuropathology image 1-2018: Golgi silver staining, the black reaction 137
Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015 134
The Acute Optic Neuritis Network (ACON): Study protocol of a non-interventional prospective multicenter study on diagnosis and treatment of acute optic neuritis 133
Investigating paraneoplastic aquaporin-4 positive neuromyelitis optica spectrum disorder through a data-driven approach 131
Neurofilament light chain levels in patients with antibodies to myelin oligodendrocyte glycoprotein (MOG-Abs) 131
Brain stimulation as a therapeutic tool in Amyotrophic Lateral Sclerosis: current status and interaction with mechanisms of altered cortical excitability 129
GFAP as a marker of astrocytic damage correlated with medication overuse in migraine 128
Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD 128
Mechanisms of nerve damage in neuropathies associated with hematological diseases: lesson from nerve biopsies 127
Analysis of inflammatory markers and tau deposits in an autopsy series of nine patients with anti-IgLON5 disease 125
A novel cell-based immunofluorescence assay for the detection of autoantibodies to myelin-associated glycoprotein 124
Peripheral neuropathy and central nervous system involvement in cryoglobulinenia. 123
Cerebrospinal fluid analysis and the determination of oligoclonal bands 123
SARS-CoV-2 antibodies in inflammatory neurological conditions: a multicentre retrospective comparative study 122
l-dopa-induced off: functional overlay in Parkinson disease 122
Review of West Nile virus epidemiology in Italy and report of a case of West Nile virus encephalitis. 121
SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses 121
Brain Volume Measures in Adults with MOG-Antibody-Associated Disease: A Longitudinal Multicenter Study 119
Autoimmune encephalitis: a retrospective monocentric experience 119
Non-demyelinating disorders mimicking and misdiagnosed as NMOSD, a literature review 118
Cerebellar involvement associated with immune checkpoint inhibitors: a systematic review 117
Infectious neuropathies 117
Persistence of anti-NMDAR antibodies in CSF after recovery from autoimmune encephalitis 117
Diagnostics of the neuromyelitis optica spectrum disorders (NMOSD) 117
Diagnostics of autoimmune encephalitis associated with antibodies against neuronal surface antigens 116
Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder 114
HCV-related central and peripheral nervous system demyelinating disorders. 112
Exposure to TNF inhibitors is rare at MOGAD presentation 112
Investigating the association between neoplasms and MOG antibody-associated disease 112
Management of antibody-mediated autoimmune encephalitis in adults and children: literature review and consensus-based practical recommendations 110
Neuronal intermediate filament paraneoplastic autoimmunity complicating avelumab therapy of Merkel cell carcinoma 110
Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum Disorder 109
NfL levels predominantly increase at disease onset in MOG-Abs-associated disorders 109
Prevalence, incidence, and season distribution of MOG antibody-associated disease in the province of Verona, Italy 109
Peripheral neuropathy and MOG-IgG: a clinical and neuropathological retrospective study 108
Diagnostics of dysimmune peripheral neuropathies 108
Serum neurofilament to Magnetic Resonance Imaging lesion area ratio differentiates spinal cord infarction from acute myelitis 108
Peripheral neuropathies during the COVID-19 pandemic: is there a relation? 108
Sporadic Creutzfeldt-Jakob disease: prion pathology in medulla oblongata-possible routes of infection and host susceptibility. 107
Diagnostics of anti-MAG antibody polyneuropathy 107
Brentuximab vedotin-induced peripheral neuropathy: looking at microtubules 107
Serum Neurofilament Light Chain in NMOSD and Related Disorders: Comparison According to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies Status 106
Lymphomatosis cerebri and anti-NMDAR antibodies: A unique constellation 104
Neuronal intermediate filament IgGs in CSF: Autoimmune Axonopathy Biomarkers 104
Neurologic sequelae of COVID-19 are determined by immunologic imprinting from previous coronaviruses 102
Superior diagnostic performance of reduced-FOV DWI versus conventional DWI MRI in anti-NMDAR encephalitis 102
Clinical Course of Neurologic Adverse Events Associated With Immune Checkpoint Inhibitors: Focus on Chronic Toxicities 101
Totale 14.785
Categoria #
all - tutte 66.477
article - articoli 64.880
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 420
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.177
Totale 132.954


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021152 0 0 0 0 0 0 0 0 0 10 73 69
2021/2022864 57 266 2 119 19 32 15 37 32 37 71 177
2022/20231.939 115 188 160 343 141 470 25 131 232 33 63 38
2023/20241.279 47 82 137 136 112 304 56 76 21 71 167 70
2024/20253.180 149 198 120 493 155 117 188 199 534 245 258 524
2025/20269.848 647 675 639 1.612 2.775 652 920 658 767 503 0 0
Totale 19.156